Prostate Cancer Canada: PSA Recommendation
http://www.prostatecancer.ca/getmed...SA-Position-Know-Your-Number-final_1.pdf.aspx
Prostate Cancer Canada’s (PCC) recommendation regarding the use of the PSA test for the early detection of prostate cancer in asymptomatic men has been reviewed given the release of recent national and international guidelines, as well as recent publications on the PSA test and prostate cancer mortality.
The purpose of this revised recommendation is to provide men and their primary care providers with information and guidance in making an informed decision regarding having a PSA test. The decision to undergo testing for prostate cancer is one that should be discussed with a man and his primary care provider as part of a shared decision making process and we hope that with this revised recommendation, men who have concerns regarding their future risk of developing prostate cancer will be encouraged to discuss the benefits and limitations of PSA testing.
PCC’s current recommendation regarding the use of the PSA test is to ‘encourage men over the age of 40, as part of their annual check-up, to initiate a conversation with their doctor about early detection (which may include PSA testing and a Digital Rectal Exam)’.
The development of our latest recommendations evolved from a comprehensive review of available scientific literature as well as listening to the views of our survivor stakeholders. Additionally, we have taken into account the views of national and international researchers and clinicians on the use of the PSA test for testing asymptomatic men.
Summary of Recommendation
Recommendation 1: Men should get a PSA test in their 40s to establish their baseline.
Recommendation 2: Men at high risk for prostate cancer should talk to their primary care provider before age 40 about prostate cancer.
Recommendation 3: At or over age 70, the decision to end PSA testing should be based on individual factors.
http://www.prostatecancer.ca/getmed...SA-Position-Know-Your-Number-final_1.pdf.aspx
Prostate Cancer Canada’s (PCC) recommendation regarding the use of the PSA test for the early detection of prostate cancer in asymptomatic men has been reviewed given the release of recent national and international guidelines, as well as recent publications on the PSA test and prostate cancer mortality.
The purpose of this revised recommendation is to provide men and their primary care providers with information and guidance in making an informed decision regarding having a PSA test. The decision to undergo testing for prostate cancer is one that should be discussed with a man and his primary care provider as part of a shared decision making process and we hope that with this revised recommendation, men who have concerns regarding their future risk of developing prostate cancer will be encouraged to discuss the benefits and limitations of PSA testing.
PCC’s current recommendation regarding the use of the PSA test is to ‘encourage men over the age of 40, as part of their annual check-up, to initiate a conversation with their doctor about early detection (which may include PSA testing and a Digital Rectal Exam)’.
The development of our latest recommendations evolved from a comprehensive review of available scientific literature as well as listening to the views of our survivor stakeholders. Additionally, we have taken into account the views of national and international researchers and clinicians on the use of the PSA test for testing asymptomatic men.
Summary of Recommendation
Recommendation 1: Men should get a PSA test in their 40s to establish their baseline.
Recommendation 2: Men at high risk for prostate cancer should talk to their primary care provider before age 40 about prostate cancer.
Recommendation 3: At or over age 70, the decision to end PSA testing should be based on individual factors.